NDC 72162-1739-05 - Lovastatin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72162-1739
- Requested NDC
- 72162-1739-05
- Package NDCs from labels
- 72162-1739-6, 72162-1739-9, 72162-1739-2, 72162-1739-7, 72162-1739-4, 72162-1739-5, 72162-1739-0, 72162-1739-05
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2025-04-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lovastatin - Bryant Ranch Prepack | Bryant Ranch Prepack | 2025-04-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-1739-0 | Lovastatin | 1000 in 1 BOTTLE | TABLET | 1000 | 104 | |
| 72162-1739-2 | Lovastatin | 100 in 1 BOTTLE | TABLET | 100 | 104 | |
| 72162-1739-4 | Lovastatin | 300 in 1 BOTTLE | TABLET | 300 | 104 | |
| 72162-1739-5 | Lovastatin | 500 in 1 BOTTLE | TABLET | 500 | 104 | |
| 72162-1739-6 | Lovastatin | 60 in 1 BOTTLE | TABLET | 60 | 104 | |
| 72162-1739-7 | Lovastatin | 120 in 1 BOTTLE | TABLET | 120 | 104 | |
| 72162-1739-9 | Lovastatin | 90 in 1 BOTTLE | TABLET | 90 | 104 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72162-1739 | LOVASTATIN TABLET [BRYANT RANCH PREPACK] | 104 | Current NDC, 7 package rows | 20250403_220a9b3c-c583-49e3-8bf0-d0c97dc9b829.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72162-1739-0 | EA - Each | 72162-1739 | 17466cd6-a469-40a8-a4e9-aeb10e754c6d | 1 | 2024-01-04 |
| 72162-1739-2 | EA - Each | 72162-1739 | fe38879a-6cdd-4f36-9199-0c94f1fe64a7 | 1 | 2023-12-05 |
| 72162-1739-4 | EA - Each | 72162-1739 | c74452e4-1acc-4bd0-ad82-538f902c10b2 | 1 | 2024-08-12 |
| 72162-1739-5 | EA - Each | 72162-1739 | 62e975f2-b710-4282-9404-15a7745e02bf | 1 | 2024-01-04 |
| 72162-1739-6 | EA - Each | 72162-1739 | c8012dff-2308-40b0-bbf3-a5367c41ee4f | 1 | 2024-08-12 |
| 72162-1739-7 | EA - Each | 72162-1739 | b5033e85-ab28-411c-83ed-0ee83c756d6f | 1 | 2023-12-05 |
| 72162-1739-9 | EA - Each | 72162-1739 | c8abddfb-bf98-4e83-b15c-363d218e3c41 | 1 | 2024-08-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lovastatin | LOVASTATIN | REMEDYREPACK INC. | 9438d8a0-ca5b-4676-aab9-d0241ccff6c9 | 2026-07-23 | Warnings, Adverse reactions | ANDA075991 197905 9LHU78OQFD |
| Lovastatin | LOVASTATIN | PD-Rx Pharmaceuticals, Inc. | e75b5808-ec66-4da7-90bc-e53611aa1b34 | 2026-06-12 | Warnings, Adverse reactions | 197905 9LHU78OQFD |
| Lovastatin | LOVASTATIN | Preferred Pharmaceuticals Inc. | 56680dfa-abe6-4587-b222-364315fd78f4 | 2026-06-03 | Warnings, Adverse reactions | ANDA075991 197903 9LHU78OQFD |
| Lovastatin | LOVASTATIN | Preferred Pharmaceuticals, Inc. | 397949f9-ce60-424f-9902-90e65a34f4de | 2026-06-03 | Warnings, Adverse reactions | 197905 9LHU78OQFD |
| Lovastatin | LOVASTATIN | Preferred Pharmaceuticals, Inc. | 22c9f2d8-7bcd-4415-bbc8-505720033966 | 2026-06-03 | Warnings, Adverse reactions | 197904 9LHU78OQFD |
| Lovastatin | LOVASTATIN | Preferred Pharmaceuticals, Inc. | ea4df37b-21e9-4dc3-83af-1be1b50bfdc9 | 2026-06-03 | Warnings, Adverse reactions | ANDA075991 197905 197904 9LHU78OQFD |
| Lovastatin | LOVASTATIN | Bryant Ranch Prepack | 030c0f79-6bb5-4876-bf8e-b7a25b25dd38 | 2026-05-29 | Warnings, Adverse reactions | 197905 9LHU78OQFD |
| Lovastatin | LOVASTATIN | Bryant Ranch Prepack | f5f265a6-2aa5-4205-9159-40133ae93ac0 | 2026-05-28 | Warnings, Adverse reactions | 197904 9LHU78OQFD |
| Lovastatin | LOVASTATIN | BluePoint Laboratories | 7b86160d-74a9-4774-b5b3-5641e686991f | 2026-05-27 | Warnings, Adverse reactions | 197905 197904 197903 9LHU78OQFD |
| Lovastatin | LOVASTATIN | REMEDYREPACK INC. | ff040b3c-6790-40d7-bd64-a4073b4a2045 | 2026-05-21 | Warnings, Adverse reactions | 197904 9LHU78OQFD |
| Lovastatin | LOVASTATIN | Lupin Pharmaceuticals, Inc. | df7ddf4f-d569-431e-81f1-9129d7043150 | 2026-05-06 | Warnings, Adverse reactions | 197905 197904 197903 9LHU78OQFD |
| Caldesene Baby | STARCH, CORN AND ZINC OXIDE | Insight Pharmaceuticals LLC | 9f12dee2-7afa-45e9-a729-0fd42bb77715 | 2026-04-22 | Warnings | O8232NY3SJ |
| Caldesene Medicated Protecting | CORNSTARCH AND ZINC OXIDE | Insight Pharmaceuticals LLC | ffc92a0f-a7cf-4a46-b2f1-089df2bbb96b | 2026-04-22 | Warnings | O8232NY3SJ |
| Lovastatin | LOVASTATIN | REMEDYREPACK INC. | a902a95f-072a-4487-99a9-109a93f8b23c | 2026-04-03 | Warnings, Adverse reactions | 197905 9LHU78OQFD |
| Lovastatin | LOVASTATIN | Legacy Pharmaceutical Packaging, LLC | a4f02fa1-3281-46fa-bd52-323e2644b6f8 | 2026-03-11 | Warnings, Adverse reactions | 197905 197904 9LHU78OQFD |
| Lovastatin | LOVASTATIN | Bryant Ranch Prepack | 7fd9d5c7-8025-4049-8b5b-ae3d22db507f | 2026-03-09 | Warnings, Adverse reactions | ANDA075991 197903 9LHU78OQFD |
| Lotrimin Daily Sweat and Odor Control | TOPICAL STARCH | Bayer HealthCare LLC. | 9ec5c80d-b550-496f-e053-2a95a90a5489 | 2026-01-16 | Warnings | O8232NY3SJ |
| Lovastatin | LOVASTATIN | Northwind Health Company, LLC | f308fe1c-23a9-6409-e053-2995a90abfd9 | 2026-01-01 | Warnings, Adverse reactions | 197905 9LHU78OQFD |
| Lovastatin | LOVASTATIN | Northwind Health Company, LLC | ca59cbd4-a4c1-aebe-e053-2a95a90ae968 | 2026-01-01 | Warnings, Adverse reactions | 197904 9LHU78OQFD |
| Lovastatin | LOVASTATIN | Northwind Health Company, LLC | db47ddae-c574-427f-e053-2a95a90aae48 | 2026-01-01 | Warnings, Adverse reactions | ANDA075991 197903 9LHU78OQFD |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.